JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.34B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.65B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.58B |
| 4 |
iShares MBS ETF
MBB
|
+$1.3B |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.18B |
Top Sells
| 1 |
Apple
AAPL
|
+$776M |
| 2 |
Johnson & Johnson
JNJ
|
+$698M |
| 3 |
Mondelez International
MDLZ
|
+$646M |
| 4 |
CVS Health
CVS
|
+$591M |
| 5 |
UnitedHealth
UNH
|
+$555M |
Sector Composition
| 1 | Technology | 13.13% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.3% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
ProShares UltraShort Euro
EUO
$33.6M
| $55K | ﹤0.01% |
2,125
+2,000
| +1,600% | +$51.8K |
|
4002
Guaranty Bancshares
GNTY
$557M
| $55K | ﹤0.01% |
2,065
-4,060
| -66% | -$108K |
|
4003
OFS Capital
OFS
$117M
| $55K | ﹤0.01% |
4,700
-169,307
| -97% | -$1.98M |
|
|
PCTI
4004
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $55K | ﹤0.01% |
10,898
-2,753
| -20% | -$13.9K |
|
|
MN
4005
DELISTED
MANNING & NAPIER, INC.
MN
| $55K | ﹤0.01% |
26,265
+26,108
| +16,629% | +$54.7K |
|
|
RBNC
4006
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $55K | ﹤0.01% |
2,465
-115
| -4% | -$2.57K |
|
4007
WisdomTree US SmallCap Earnings Fund
EES
$635M
| $54K | ﹤0.01% |
1,500
| – | – |
|
4008
Kezar Life Sciences
KZR
$28.9M
| $54K | ﹤0.01% |
306
+174
| +132% | +$30.7K |
|
4009
Omega Flex
OFLX
$340M
| $54K | ﹤0.01% |
710
-3,315
| -82% | -$252K |
|
4010
TFS Financial
TFSL
$3.75B
| $54K | ﹤0.01% |
3,270
+220
| +7% | +$3.63K |
|
4011
Vanguard S&P Small-Cap 600 ETF
VIOO
$3.04B
| $54K | ﹤0.01% |
776
| – | – |
|
4012
Cadiz
CDZI
$322M
| $53K | ﹤0.01% |
5,516
-259
| -4% | -$2.49K |
|
4013
i3 Verticals
IIIV
$724M
| $53K | ﹤0.01% |
2,223
+251
| +13% | +$5.98K |
|
4014
VanEck Pharmaceutical ETF
PPH
$627M
| $53K | ﹤0.01% |
880
-907
| -51% | -$54.6K |
|
4015
SmartFinancial
SMBK
$627M
| $53K | ﹤0.01% |
2,809
-94
| -3% | -$1.77K |
|
4016
Spyre Therapeutics
SYRE
$945M
| $53K | ﹤0.01% |
267
+99
| +59% | +$19.7K |
|
|
NYMX
4017
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $53K | ﹤0.01% |
26,913
+1,098
| +4% | +$2.16K |
|
4018
Coda Octopus Group
CODA
$98.5M
| $52K | ﹤0.01% |
+5,590
| New | +$52K |
|
4019
Gold Fields
GFI
$33.7B
| $52K | ﹤0.01% |
13,933
-295,138
| -95% | -$1.1M |
|
4020
Green Brick Partners
GRBK
$3.21B
| $52K | ﹤0.01% |
5,985
-281
| -4% | -$2.44K |
|
4021
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $52K | ﹤0.01% |
2,880
+1,222
| +74% | +$22.1K |
|
4022
Arq
ARQ
$306M
| $52K | ﹤0.01% |
4,510
-211
| -4% | -$2.43K |
|
|
ONIT
4023
Onity Group Inc.
ONIT
$367M
| $52K | ﹤0.01% |
1,912
-89
| -4% | -$2.42K |
|
|
MLVF
4024
DELISTED
Malvern Bancorp, Inc.
MLVF
| $52K | ﹤0.01% |
2,564
-2,323
| -48% | -$47.1K |
|
|
CNST
4025
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $52K | ﹤0.01% |
3,848
+1,779
| +86% | +$24K |
|